Paper278642
Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer.
Lerner HJ. Cancer Treat Rep, 1978. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer. Papers, record 278642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/278642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Chlorambucil | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18579112 | Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. | Am J Ophthalmol | 2008 | https://conductscience.org/library/papers/18579112 | PubMed |
| 7340986 | Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7340986 | PubMed |
| 6786872 | Chemically induced leukemia in humans. | Environ Health Perspect | 1981 | https://conductscience.org/library/papers/6786872 | PubMed |
| 6756459 | The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6756459 | PubMed |
| 6708398 | Adjuvant chemotherapy of breast cancer: hope--reality--hazard? | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6708398 | PubMed |
| 6705132 | The efficiency of protective gloves used in the handling of cytotoxic drugs. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6705132 | PubMed |
| 6377542 | Immunosuppressive therapy in the treatment of autoimmune diseases. | Springer Semin Immunopathol | 1984 | https://conductscience.org/library/papers/6377542 | PubMed |
| 3544282 | Treatment of systemic lupus erythematosus. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/3544282 | PubMed |
| 2250264 | Survival in acute non-lymphocytic leukaemia following breast cancer. | J R Soc Med | 1990 | https://conductscience.org/library/papers/2250264 | PubMed |
| 2191847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
| 497405 | Tolerance of hemopoiesis for repeated cytotoxic drug therapy. | Blut | 1979 | https://conductscience.org/library/papers/497405 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/278642
GET https://conductscience.org/api/papers/v1/278642/authors